[Infectious complications as a consequence of treatment with nucleoside analogs and monoclonal antibodies].
Maschmeyer
G
G
Medizinische Klinik, Abt. Hämatologie und Onkologie, Klinikum Ernst von Bergmann, Potsdam. gmaschmeyer@klinikumevb.de
Haas
A
A
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007239:Infections / Q000139:chemically induced* / Q000276:immunology; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000276:immunology; D009705:Nucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D016377:Organ Transplantation; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D009705:Nucleosides